What is My Company Worth? Understanding How Business Value is Determined.

One of the first questions business owners ask when considering a sale is:

"What is my company worth?"

The answer often surprises and frustrates them.

Many owners assume value is based on revenue, the amount they have invested over the years, or what they need to retire comfortably. While those factors may matter personally, they are not how buyers determine value.

In the mergers and acquisitions (M&A) world, value is typically based on a company's ability to generate future cash flow and the level of risk associated with those earnings. In other words, buyers are not purchasing your past performance; they are investing in your future.

Understanding EBITDA

The starting point for most business valuations is EBITDA, which stands for:

Earnings Before Interest, Taxes, Depreciation, and Amortization

EBITDA is used because it measures the profitability of a business before financing decisions, tax strategies, and certain accounting treatments. It allows buyers to compare companies on a more consistent basis.

Think of EBITDA as a way to evaluate the operating performance of a business independent of how it is financed or structured.

Why Buyers Use Adjusted EBITDA

For privately held businesses, the reported EBITDA on financial statements often does not reflect the true earnings power of the company.

Many owner-operated businesses include expenses that a future buyer would not incur, such as:

• Excess owner compensation

• Personal expenses paid through the business

• One-time legal or consulting costs

• Non-recurring events

• Above-market family salaries

• Other discretionary spending

These adjustments are added back to arrive at Adjusted EBITDA, which represents the normalized earnings a buyer expects to receive after acquisition.

The goal is to answer a simple question:

"What would this business earn under typical market ownership?"

Where Do Valuation Multiples Come From?

Most lower middle market businesses are valued using a multiple of Adjusted EBITDA.

The formula looks like this:

Enterprise Value = Adjusted EBITDA × Valuation Multiple

For example:

• Adjusted EBITDA: $2 million

• Valuation Multiple: 6x

Estimated Enterprise Value: $12 million

But where does that multiple come from?

The multiple is derived from actual market transactions, public company valuations, industry trends, and buyer demand. Over time, investors have observed that businesses with similar characteristics tend to sell within predictable valuation ranges.

The multiple acts as a shortcut for a much more complex financial analysis known as a Discounted Cash Flow (DCF) model, which estimates the present value of future earnings.

What Buyers Are Really Evaluating

When a buyer says they will pay "7x EBITDA," they are not saying they expect to get their money back in seven years.

Instead, they are making a judgment about three factors:

1. Growth Potential

A business that is growing rapidly is likely to generate significantly more earnings in the future than it does today.

If a company earns $1 million today but is expected to earn $2 million or $3 million within a few years, buyers are often willing to pay a higher multiple.

Growth creates value.

2. Risk

Risk has a significant impact on valuation.

A company with diversified referral sources, stable staffing, strong compliance systems, and experienced management is viewed as less risky than a business dependent on a single owner, customer, or payer relationship.

The lower the perceived risk, the higher the valuation multiple.

In fact, many investors believe:

Risk reduces value faster than growth increases it.

3. Future Exit Opportunities

Many buyers, particularly private equity firms, are thinking several years ahead.

They evaluate whether they can grow the business, improve operations, complete acquisitions, and eventually sell the company at a higher value.

A business with a strong platform, scalable infrastructure, and attractive market position often commands a higher multiple because buyers see future opportunities beyond the current earnings.

Why Healthcare Businesses Often Trade at Different Multiples

In healthcare and behavioral health transactions, the quality and sustainability of earnings often matter more than the earnings themselves.

Buyers closely evaluate factors such as:

• Referral source diversity

• Payer mix

• Compliance history

• Clinical leadership

• Workforce stability

• Census consistency

• Growth opportunities

• Regulatory environment

Two healthcare organizations with identical EBITDA can have dramatically different valuations depending on these factors.

The Real Driver of Value

Ultimately, a company's value is not determined by revenue, years in business, or even current profitability alone.

Value is determined by what sophisticated buyers believe the business can generate in the future and how confident they are in achieving those results.

This is why increasing value is not always about improving EBITDA.

Sometimes the greatest increase in value comes from:

• Reducing founder dependence

• Strengthening leadership

• Diversifying referral sources

• Improving financial reporting

• Demonstrating recurring revenue

• Building scalable systems

These actions reduce risk, improve confidence, and often have a greater impact on valuation multiples than incremental earnings growth.

The Answer:

Business valuation is both an art and a science.

The science comes from financial performance and market data. The art comes from how buyers perceive future growth opportunities and risk.

At the end of the day, buyers are not purchasing what your business earned last year. They are purchasing what they believe it will earn tomorrow.

Understanding that distinction is one of the most important steps a business owner can take when preparing for a successful sale.